Provided by Tiger Trade Technology Pte. Ltd.

Geron

1.40
-0.1400-9.09%
Post-market: 1.410.0100+0.71%19:57 EDT
Volume:19.25M
Turnover:27.99M
Market Cap:893.70M
PE:-11.18
High:1.54
Open:1.51
Low:1.40
Close:1.54
52wk High:2.01
52wk Low:1.04
Shares:638.36M
Float Shares:534.08M
Volume Ratio:0.87
T/O Rate:3.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1252
EPS(LYR):-0.1252
ROE:-32.99%
ROA:-5.53%
PB:3.96
PE(LYR):-11.18

Loading ...

Geron Unveils New Data Showing RYTELO Improves Outcomes in Lower-Risk MDS

Reuters
·
Dec 08, 2025

Geron Q3 EPS USD -0.03

Reuters
·
Nov 20, 2025

Wedbush Cuts Price Target on Geron to $5 From $6, Keeps Outperform Rating

MT Newswires Live
·
Nov 06, 2025

Stock Track | Geron Soars 9.17% Pre-Market Following Q3 Earnings and Positive Analyst Outlook

Stock Track
·
Nov 06, 2025

Stock Track | Geron (GERN) Surges 9.17% in Pre-market Following Positive Analyst Outlook Despite Mixed Q3 Results

Stock Track
·
Nov 06, 2025

Stock Track | Geron (GERN) Plunges 5.50% After Mixed Q3 Earnings Report

Stock Track
·
Nov 06, 2025

Stock Track | Geron Plunges 5.50% Following Mixed Q3 Earnings Report and Missed Revenue Target

Stock Track
·
Nov 06, 2025

Stock Track | Geron Soars 5.50% Despite Mixed Q3 Results as Analysts Maintain Positive Outlook

Stock Track
·
Nov 06, 2025

Stock Track | Geron Soars 5.50% After Q3 Earnings and Maintained Buy Ratings

Stock Track
·
Nov 06, 2025

Geron Corporation’s Earnings Call: Mixed Sentiments and Future Prospects

TIPRANKS
·
Nov 06, 2025

Buy Rating Maintained for Geron Despite Rytelo Sales Dip, Strong Financial Position Supports Strategic Shift

TIPRANKS
·
Nov 06, 2025

Geron Is Maintained at Buy by Needham

Dow Jones
·
Nov 06, 2025

Strategic Initiatives and Market Expansion Drive Buy Rating for Geron

TIPRANKS
·
Nov 06, 2025

Stock Track | Geron Plummets 5.22% Pre-market After Q3 Revenue Miss Despite In-Line EPS

Stock Track
·
Nov 05, 2025

Stock Track | Geron Soars 8.70% Pre-Market on Strong Q3 Results and Improved 2025 Outlook

Stock Track
·
Nov 05, 2025

Geron reports Q3 EPS (3c), consensus (4c)

TIPRANKS
·
Nov 05, 2025

Stock Track | Geron Plunges 5.22% Pre-market Following Q3 Sales Miss

Stock Track
·
Nov 05, 2025

Geron Expects 2025 Operating Expenses Will Be Between $250M And $260M vs. Approximately $270M-$285M Prior

Benzinga
·
Nov 05, 2025

Geron Q3 EPS $(0.03), Inline, Sales $47.227M Miss $52.881M Estimate

Benzinga
·
Nov 05, 2025

Hematology drug developer Geron Q3 narrows net loss narrows, driven by RYTELO sales

Reuters
·
Nov 05, 2025